Close
Nordic 9Nordic 9

Global Corporate Finance (investor - Private Equity)

Spain globalcorporatefinance.es
See something wrong or missing? Let us know
Offices:Madrid
Average round investment:11.65M USD
Average number per year:1.0
Distribution: 2025 (1)
Portfolio companies: Italy Ulisse Biomed
Mostly invests in: Italy Italy (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Global Corporate Finance

Name Criteria
Germany 2invest
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Italy Alef 6
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Ace Ventures
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Pharma, Software Services
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Italy Ersel
82%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Black Opal Ventures
81%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Netherlands dsm-firmenich Ventures
81%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Italy Claris Ventures
81%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Pharma, Software Services
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Netherlands DSM Venturing
81%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Pharma, Software Services
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
Switzerland SAGANA
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
United States Green Sands Equity
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Pharma, Software Services
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Top